{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:25:25Z","timestamp":1772202325283,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jsat.2021.108350","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T19:33:53Z","timestamp":1614972833000},"page":"108350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine"],"prefix":"10.1016","volume":"127","author":[{"given":"Kirsten","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Baschirotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Walcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"G\u00f6rne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Backmund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Scherbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Verthein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2021.108350_bb0005","first-page":"12","article-title":"Grundlagen der Substitution bei Heroinabh\u00e4ngigen","volume":"1","author":"Backmund","year":"2009","journal-title":"HIV&more"},{"issue":"3","key":"10.1016\/j.jsat.2021.108350_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: The foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1016\/j.jsat.2021.108350_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jphs.2020.06.004","article-title":"Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care","volume":"144","author":"Baschirotto","year":"2020","journal-title":"Journal of Pharmacological Sciences"},{"issue":"4","key":"10.1016\/j.jsat.2021.108350_bb0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/add.12440","article-title":"Maintenance treatment for opioid dependence with slow-release oral morphine: A randomized cross-over, non-inferiority study versus methadone","volume":"109","author":"Beck","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2021.108350_bb0025","doi-asserted-by":"crossref","unstructured":"Brack, J. (2015). Deutsche Gesellschaft f\u00fcr Suchtmedizin (DGS) e. V., Die AOK (Nordwest) treibt es auf die Spitze: Regressforderung wegen Verordnung von Substitol. Suchttherapie, 16.","DOI":"10.1055\/s-0035-1552997"},{"key":"10.1016\/j.jsat.2021.108350_bb0030","unstructured":"Busch, M., Haas, S., Weigl, M., Wirl, C., Horvath, I., & St\u00fcrzlinger, H. (2007). [Long-term substitution treatment of opioid dependent people]. In Deutsches Institut f\u00fcr Medizinische Dokumentation und Information (Ed.), (1 ed.). (K\u00f6ln)."},{"issue":"2","key":"10.1016\/j.jsat.2021.108350_bb0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harvard Review of Psychiatry"},{"key":"10.1016\/j.jsat.2021.108350_bb0040","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1360-0443.1992.tb02719.x","article-title":"Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: The Opiate Treatment Index","volume":"87","author":"Darke","year":"1992","journal-title":"British Journal of Addiction"},{"key":"10.1016\/j.jsat.2021.108350_bb0045","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1360-0443.1991.tb01707.x","article-title":"A scale for estimating the health status of opioid users","volume":"86","author":"Darke","year":"1991","journal-title":"British Journal of Addiction"},{"issue":"12","key":"10.1016\/j.jsat.2021.108350_bb0050","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016","volume":"5","author":"Degenhardt","year":"2018","journal-title":"The Lancet Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2021.108350_bb0055","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2009.05.021","article-title":"Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved","volume":"105","author":"Degenhardt","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"9904","key":"10.1016\/j.jsat.2021.108350_bb0060","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(13)61530-5","article-title":"Global burden of disease attributable to illicit drug use and dependence: Findings from the Global Burden of Disease Study 2010","volume":"382","author":"Degenhardt","year":"2013","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/j.jsat.2021.108350_bb0065","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1360-0443.1997.tb02866.x","article-title":"Patterns of symptom complaints in methadone maintenance patients","volume":"92","author":"Dyer","year":"1997","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.jsat.2021.108350_bb0070","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1360-0443.2005.001128.x","article-title":"Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy","volume":"100","author":"Eder","year":"2005","journal-title":"Addiction (Abingdon, England)"},{"issue":"12","key":"10.1016\/j.jsat.2021.108350_bb0075","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archinte.166.12.1280","article-title":"Drug-induced long QT syndrome in injection drug users receiving methadone: High frequency in hospitalized patients and risk factors","volume":"166","author":"Ehret","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.jsat.2021.108350_bb0080","series-title":"European drug report: Trends and developments","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2019"},{"issue":"2","key":"10.1016\/j.jsat.2021.108350_bb0085","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/JCP.0000000000000288","article-title":"Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: A randomized, crossover clinical trial","volume":"35","author":"Falcato","year":"2015","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2021.108350_bb0090","unstructured":"Federal Institute for Drugs and Medical Devices. (2016). [Report on the Substitution Register]."},{"key":"10.1016\/j.jsat.2021.108350_bb0095","unstructured":"Federal Institute for Drugs and Medical Devices. (2020). [Report on the Substitution Register]."},{"issue":"1","key":"10.1016\/j.jsat.2021.108350_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000081410","article-title":"Eyes wide shut? A conceptual and empirical critique of methadone maintenance treatment","volume":"11","author":"Fischer","year":"2005","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2021.108350_bb0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1055\/s-0030-1270518","article-title":"The usefulness of the Brief Symptom Inventory 18 (BSI-18) in psychotherapeutic patients","volume":"61","author":"Franke","year":"2011","journal-title":"Psychotherapie, Psychosomatik, Medizinische Psychologie"},{"issue":"1","key":"10.1016\/j.jsat.2021.108350_bb0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12874-016-0283-3","article-title":"Psychometric analysis of the brief symptom inventory 18 (BSI-18) in a representative German sample","volume":"17","author":"Franke","year":"2017","journal-title":"BMC Medical Research Methodology"},{"key":"10.1016\/j.jsat.2021.108350_bb0115","unstructured":"German Society for Addiction Medicine. (2015). dgs-info extra zur Einf\u00fchrung von oralem retardierten Morphin (Substitol\u00ae) in der Substitutionsbehandlung. Retrieved from: https:\/\/web.archive.org\/web\/20150923214201\/http:\/\/www.dgsuchtmedizin.de\/newsletter\/fruehere-ausgaben\/dgs-info-extra-zur-einfuehrung-von-oralem-retardierten-morphin-substitolr-in-der-substitutionsbehandlung\/. (Accessed 12 July 2020)."},{"issue":"5","key":"10.1016\/j.jsat.2021.108350_bb0120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0306-4603(90)90036-W","article-title":"The development of a short opiate withdrawal scale (SOWS)","volume":"15","author":"Gossop","year":"1990","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.jsat.2021.108350_bb0125","article-title":"Oral substitution treatment of injecting opioid users for prevention of HIV infection","volume":"8","author":"Gowing","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1016\/j.jsat.2021.108350_bb0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jsat.2014.05.012","article-title":"Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence","volume":"47","author":"H\u00e4mmig","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2021.108350_bb0135","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2105\/AJPH.85.1.83","article-title":"Heroin use during methadone maintenance treatment: The importance of methadone dose and cocaine use","volume":"85","author":"Hartel","year":"1995","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2021.108350_bb0140","series-title":"Federal regulation of methadone treatment","author":"Institute of Medicine","year":"1995"},{"issue":"6","key":"10.1016\/j.jsat.2021.108350_bb0145","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1365-2125.2011.03923.x","article-title":"Slow-release oral morphine for opioid maintenance treatment: A systematic review","volume":"71","author":"Jegu","year":"2011","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1016\/j.jsat.2021.108350_bb0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.drugalcdep.2010.06.009","article-title":"Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence","volume":"112","author":"Karow","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108350_bb0155","unstructured":"Kassen\u00e4rztliche Vereinigung Saarland (KVS). (2016). Anleitung zur wirtschaftlichen Verordnungsweise im Rahmen der Arznei- und Verbandmittelvereinbarung der KVS. Morphin zur Substitutionsbehandlung bei Opiatabh\u00e4ngigkeit. Retrieved from: https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwietOjWlb_tAhUP_aQKHT2MBZEQFjABegQIBhAC&url=https%3A%2F%2Fwww.kvsaarland.de%2Fdocuments%2F10184%2F1444961%2FSubstitol%25C2%25AE%2B-%2BMorphin%2Bzur%2BSubstitutionsbehandlung%2Bbei%2BOpiatabh%25C3%25A4ngigkeit.pdf%2F449fd620-cef9-40fc-b1a5-24fe1c955f61%3Fversion%3D1.1%26t%3D1481019060000%26download%3Dtrue&usg=AOvVaw056-ODn4dlGFlHX1hXwIxc. (Accessed 08 December 2020)."},{"issue":"4","key":"10.1016\/j.jsat.2021.108350_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025799","article-title":"Slow release oral morphine versus methadone for the treatment of opioid use disorder","volume":"9","author":"Klimas","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jsat.2021.108350_bb0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0740-5472(90)90005-B","article-title":"A treatment crisis: Cocaine use by clients in methadone maintenance programs","volume":"7","author":"Kolar","year":"1990","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1016\/j.jsat.2021.108350_bb0170","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-137-6-200209170-00010","article-title":"Torsade de pointes associated with very-high-dose methadone","volume":"137","author":"Krantz","year":"2002","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1016\/j.jsat.2021.108350_bb0175","first-page":"137","article-title":"Estimation of the number of people with opioid addiction in Germany","volume":"116","author":"Kraus","year":"2019","journal-title":"Deutsches \u00c4rzteblatt International"},{"issue":"6","key":"10.1016\/j.jsat.2021.108350_bb0180","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jama.1973.03220060039009","article-title":"Medical safety and side effects of methadone in tolerant individuals","volume":"223","author":"Kreek","year":"1973","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jsat.2021.108350_bb0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jsat.2006.11.009","article-title":"Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients","volume":"33","author":"Maremmani","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108350_bb0190","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2021.108350_bb0195","unstructured":"Medical Dictionary for Regulatory Activities. (2017). Introductory Guide. MedDRA\u00ae Version 20.1."},{"issue":"9","key":"10.1016\/j.jsat.2021.108350_bb0200","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1360-0443.2011.03463.x","article-title":"Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial","volume":"106","author":"Reimer","year":"2011","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2021.108350_bb0205","first-page":"31","article-title":"Ergebnisse der Methadonsubstitution in Deutschland - eine qualitative und quantitative Zusammenfassung","volume":"4","author":"Reuter","year":"2002","journal-title":"Suchtmedizin in Forschung und Praxis"},{"issue":"3","key":"10.1016\/j.jsat.2021.108350_bb0210","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/15622975.2011.561872","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence","volume":"12","author":"Soyka","year":"2011","journal-title":"The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.jsat.2021.108350_bb0215","first-page":"5","article-title":"Opiatabh\u00e4ngige in Substitutionsbehandlung in \u00d6sterreich: Ergebnisse einer Querschnittstudie","volume":"31","author":"Springer","year":"2008","journal-title":"Wiener Zeitschrift f\u00fcr Suchtforschung"},{"issue":"1","key":"10.1016\/j.jsat.2021.108350_bb0220","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13011-018-0187-9","article-title":"Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study","volume":"14","author":"Strada","year":"2019","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.jsat.2021.108350_bb0225","first-page":"1","article-title":"The history of opioid substitution treatment in Germany","volume":"8","author":"Ullmann","year":"2011","journal-title":"Acceptance-Oriented Drug Work"},{"issue":"2","key":"10.1016\/j.jsat.2021.108350_bb0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000368572","article-title":"Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: Results of a randomized crossover study","volume":"21","author":"Verthein","year":"2015","journal-title":"European Addiction Research"},{"issue":"6","key":"10.1016\/j.jsat.2021.108350_bb0235","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1360-0443.2008.02185.x","article-title":"Long-term effects of heroin-assisted treatment in Germany","volume":"103","author":"Verthein","year":"2008","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2021.108350_bb0240","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0955-3959(97)00012-1","article-title":"Substitution treatment with methadone in Germany: Politics, programmes and results","volume":"9","author":"Verthein","year":"1998","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.jsat.2021.108350_bb0245","series-title":"Schlussbericht an das Bundesministerium f\u00fcr Gesundheit (F\u00f6rderkennzeichen IIA2-2507DSM411): Institut f\u00fcr Klinische Psychologie und Psychotherapie & Center of Clinical Epidemiology and Longitudinal Studies","article-title":"Predictors, Moderators and Outcome of Substitution Treatments (PREMOS) \u2013 Effekte der langfristigen Substitution Opioidabh\u00e4ngiger: Pr\u00e4diktoren, Moderatoren und Outcome","author":"Wittchen","year":"2011"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:54:18Z","timestamp":1760039658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221000763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":49,"alternative-id":["S0740547221000763"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108350","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108350"}}